Gabapentinoids and unexplained death in general practice: Case series and feasibility study arising from a critical incident

Key Points

• The aim is to investigate the relationship between gabapentinoids and unexplained deaths in outpatient settings.
• Case series analysis of gabapentinoid-related deaths
• Review of toxicology reports from Coroner's offices
• Examination of polypharmacy effects in patients
• Unexplained deaths linked to gabapentinoids noted in complex patients
• Need for updated clinical practice guidelines identified
• Toxicology reports provide critical insights into mortality cases

Abstract